SmPC - Lisinopril 5mg Tablets: Change history
View Summary of Product Characteristics (SmPC - Lisinopril 5mg Tablets)
Last updated on this site: 24 Jul 2025
To update sections 4.3 and 4.5 of the SmPC in line with the reference product Zestril 5, 10, 20mg Tablets (PL 43252/0031, 0032, 0033; MAH: Atnahs Pharma UK Ltd).
View Summary of Product Characteristics (SmPC - Lisinopril 5mg Tablets)
Last updated on this site: 24 Jul 2025
To update sections 4.3 and 4.5 of the SmPC in line with the reference product Zestril 5, 10, 20mg Tablets (PL 43252/0031, 0032, 0033; MAH: Atnahs Pharma UK Ltd).
-
Changes: (Updated: 24 Jul 2025)
To update sections 4.3 and 4.5 of the SmPC in line with the reference product Zestril 5, 10, 20mg Tablets (PL 43252/0031, 0032, 0033; MAH: Atnahs Pharma UK Ltd).
-
Changes: (Updated: 05 Nov 2024)
Renewal approval
-
Changes: (Updated: 13 Jan 2023)
To update sections 4.4 and 4.5 of the SmPC and sections 2, 4 and 6 of PIL in line with the reference product, Zestril (PL 43252/0031, PL43252/0032, PL 43252/0033).
-
Changes: (Updated: 21 Sep 2022)
Initial upload